Construction and Characterization of a New Chimeric Antibody Against HER2
Mohammad Mehdi Amiri(Tehran University of Medical Sciences), Fazel Shokri(Tehran University of Medical Sciences), Mahshid Maddah(Academic Center for Education, Culture and Research), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Motahareh Bahadori(Academic Center for Education, Culture and Research), Jalal Khoshnoodi(University of Tehran), Hodjatallah Rabbani(Biotechnology Research Center), Mahmood Jeddi‐Tehrani(Academic Center for Education, Culture and Research), Tohid Kazemi(Tehran University of Medical Sciences)
Cited by 11
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
|Journal of Cellular Physiology|2017|150